Marking a milestone in precision oncology, Concord treats a rare choroidal melanoma case with cutting-edge proton therapy.

Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE: CCM), which subsidiary is listed on the Main Board of The ...

Public input is sought on the replacement of a bridge north of Clarinda as part of a federal grant application process.

People online are always talking about new tech, and the Vision Beam is no different. We’ve looked through lots of ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 ...

Beam Therapeutics Inc. (BEAM) shares ended the last trading session 5.7% higher at $21.46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Beam Therapeutics Inc. research and ratings by Barron's. View BEAM revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.